US2017035656A1PendingUtilityA1
Multi-layered orally disintegrating tablet and the manufacture thereof
Assignee: JOHNSON & JOHNSON CONSUMER INCPriority: Sep 24, 2009Filed: Oct 18, 2016Published: Feb 9, 2017
Est. expirySep 24, 2029(~3.2 yrs left)· nominal 20-yr term from priority
A61P 37/08A61P 29/00B30B 11/085A61K 9/145B29C 43/146A61K 9/2031A61K 9/146A61K 9/0056A61K 9/2036B29C 43/006A61K 31/167B30B 15/34A61K 9/205B29C 2043/3628B30B 11/10A61K 31/138B30B 11/027A61K 9/2095A61K 9/2018A61J 3/10A61K 31/4545A61K 9/2086
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention features a tablet containing a first layer and a second layer, wherein: (i) the first layer includes a pharmaceutically active agent and the composition of the first layer is different from the composition of the second layer; (ii) the tablet has a density less than about 0.8 g/cc; and (iii) the tablet disintegrates in the mouth when placed on the tongue in less than about 30 seconds.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A process for making a tablet comprising a first layer and a second layer, said method comprising:
adding a first powder blend to a die platen, wherein said first powder blend comprises a pharmaceutically active agent and a binder; adding a second powder blend to said die platen, wherein said second powder blend comprises a binder and wherein the composition of said second powder blend is different from the composition of said first powder blend; tamping said first powder blend and second powder blend in said die platen to form a tamped tablet shape; and applying energy to said tamped tablet shape for a sufficient period of time to activate said binders within said tablet shape to fuse said tablet shape into said tablet such that said tablet has a density less than about 0.8 g/cc and said tablet disintegrates in the mouth when placed on the tongue in less than about 30 seconds.
2 . The process of claim 1 , wherein said binder within said first powder blend and said binder within said second powder blend are meltable materials having a melting point of from about 30° C. to about 140° C. and said tablet shape is exposed to said energy for a sufficient period of time to melt or soften said binders.
3 . The process of claim 1 , wherein said binder within said first powder blend is a RF-meltable binder, and said tablet shape is exposed to RF energy for a sufficient period of time to melt or soften said RF-meltable binder.
4 . The process of claim 1 , wherein said first powder blend comprises a RF-heatable material, and said tablet shape is exposed to RF energy for a sufficient period of time to heat said RF-heatable material such that said RF-heatable material melts or softens said binder within said first powder blend.
5 . The process of claim 1 , wherein said binder within said first powder blend and said binder within said second powder blend are water-activating binding materials, said first powder blend and said second powder blend further comprise water-containing materials, and said tablet shape is exposed to said energy for a sufficient period of time to heat the water-containing materials above their dehydration temperature.
6 . The process of claim 1 , wherein said first powder blend comprises particles comprising said first pharmaceutically active agent wherein said particles are coated with said binder.
7 . The process of claim 1 , wherein said process further comprises tamping said first powder blend prior to adding said second powder blend to said die platen.
8 . The process of claim 1 , wherein the surface of said tablet is further exposed to infrared energy wherein the majority of the wavelength of said infrared energy from about 0.5 to about 5 micrometers.
9 . The process of claim 1 wherein said tamping step comprises tamping at a pressure of less than about 1000 pounds per square inch.
10 . The process of claim 1 wherein said tamping of said first powder blend is done at a pressure of less than about 1000 pounds per square inch prior to adding said second powder blend.Join the waitlist — get patent alerts
Track US2017035656A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.